• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辅助性T细胞22作为慢性炎症性皮肤病中的新角色。

T-helper 22 cells as a new player in chronic inflammatory skin disorders.

作者信息

Mirshafiey Abbas, Simhag Anita, El Rouby Nadia M M, Azizi Gholamreza

机构信息

Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Karolinska Institutet Science Park AB, Huddinge, Sweden.

出版信息

Int J Dermatol. 2015 Aug;54(8):880-8. doi: 10.1111/ijd.12883.

DOI:10.1111/ijd.12883
PMID:26183243
Abstract

T-helper 22 (Th22) cell is a new subset of CD4+ T cells that secrets interleukin (IL)-22 but not IL-17 or interferon-γ. Th22 is distinct from Th17 and other known CD4+ T-cell subsets with distinguished gene expression and function. Th22 subsets have chemokine receptors CCR6+ CCR4+ CCR10+ phenotype and aryl hydrocarbon receptor as the key transcription factor. This T-helper subset, by producing cytokines such as IL-22, IL-13, and tumor necrosis factor-α, is implicated in the pathogenesis of inflammatory skin disorder. This review discusses the role of Th22 and its cytokine IL-22 in the immunopathogenesis of inflammatory skin disorders such as psoriasis and atopic dermatitis.

摘要

辅助性T细胞22(Th22)是CD4 + T细胞的一个新亚群,它分泌白细胞介素(IL)-22,但不分泌IL-17或干扰素-γ。Th22与Th17及其他已知的CD4 + T细胞亚群不同,具有独特的基因表达和功能。Th22亚群具有趋化因子受体CCR6 + CCR4 + CCR10 +表型,并且芳烃受体是关键转录因子。这个辅助性T细胞亚群通过产生IL-22、IL-13和肿瘤坏死因子-α等细胞因子,参与炎症性皮肤病的发病机制。本文综述了Th22及其细胞因子IL-22在银屑病和特应性皮炎等炎症性皮肤病免疫发病机制中的作用。

相似文献

1
T-helper 22 cells as a new player in chronic inflammatory skin disorders.辅助性T细胞22作为慢性炎症性皮肤病中的新角色。
Int J Dermatol. 2015 Aug;54(8):880-8. doi: 10.1111/ijd.12883.
2
Th22 cells in autoimmunity: a review of current knowledge.自身免疫中的Th22细胞:当前知识综述
Eur Ann Allergy Clin Immunol. 2015 Jul;47(4):108-17.
3
The role of IL-22 and Th22 cells in human skin diseases.IL-22 和 Th22 细胞在人类皮肤疾病中的作用。
J Dermatol Sci. 2013 Oct;72(1):3-8. doi: 10.1016/j.jdermsci.2013.04.028. Epub 2013 May 3.
4
IL-22 Produced by T helper Cell 22 as a New player in the Pathogenesis of Immune Thrombocytopenia.辅助性T细胞22产生的白细胞介素-22在免疫性血小板减少症发病机制中作为新角色。
Endocr Metab Immune Disord Drug Targets. 2015;15(3):242-50. doi: 10.2174/1871530315666150331154733.
5
IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.来自银屑病皮肤斑块的产生白细胞介素-17的CD8 + T淋巴细胞是分泌与辅助性T细胞17相关细胞因子的细胞毒性效应细胞。
J Leukoc Biol. 2009 Aug;86(2):435-43. doi: 10.1189/JLB.0109046.
6
Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention.辅助性 T 细胞 22 在炎症和自身免疫性疾病中的作用:治疗干预的前景。
Mol Cell Biochem. 2011 Jul;353(1-2):41-6. doi: 10.1007/s11010-011-0772-y. Epub 2011 Mar 8.
7
Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.辅助性 T 细胞 17 型和 22 型在红皮病型银屑病和特应性皮炎中的免疫重叠。
JAMA Dermatol. 2015 Jul;151(7):753-60. doi: 10.1001/jamadermatol.2015.2.
8
Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.Th22 细胞代表了一类独特的人类 T 细胞亚群,参与表皮免疫和重塑。
J Clin Invest. 2009 Dec;119(12):3573-85. doi: 10.1172/JCI40202. Epub 2009 Nov 16.
9
IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.尽管产生白细胞介素-17的辅助性T细胞17(TH17 T细胞)数量减少,但产生白细胞介素-22的“T22”T细胞导致特应性皮炎中白细胞介素-22上调。
J Allergy Clin Immunol. 2009 Jun;123(6):1244-52.e2. doi: 10.1016/j.jaci.2009.03.041. Epub 2009 May 12.
10
Expression of the T-helper 2-specific chemokine receptor CCR4 on CCR10-positive lymphocytes in atopic dermatitis skin but not in psoriasis skin.T辅助2特异性趋化因子受体CCR4在特应性皮炎皮肤而非银屑病皮肤的CCR10阳性淋巴细胞上表达。
Br J Dermatol. 2003 Sep;149(3):457-63. doi: 10.1046/j.1365-2133.2003.05505.x.

引用本文的文献

1
Unlocking the molecular pathway of atopic dermatitis: journey so far and roads ahead.揭示特应性皮炎的分子途径:迄今为止的历程与未来之路。
Inflammopharmacology. 2025 Aug 18. doi: 10.1007/s10787-025-01900-0.
2
Tissue-Resident Th2 Cells in Type 2 Immunity and Allergic Diseases.2型免疫和过敏性疾病中的组织驻留Th2细胞
Immunol Rev. 2025 Mar;330(1):e70006. doi: 10.1111/imr.70006.
3
Different polarization and functionality of CD4+ T helper subsets in people with post-COVID condition.不同极化和功能的 CD4+ T 辅助细胞亚群在新冠病毒感染后患者中的表现。
Front Immunol. 2024 Aug 27;15:1431411. doi: 10.3389/fimmu.2024.1431411. eCollection 2024.
4
Th22 is the effector cell of thymosin β15-induced hair regeneration in mice.Th22是胸腺素β15诱导小鼠毛发再生的效应细胞。
Inflamm Regen. 2024 Jan 8;44(1):3. doi: 10.1186/s41232-023-00316-z.
5
Anti-inflammatory and immunomodulatory effects of polysaccharide extracted from Wuguchong (maggot) on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice.五谷虫(蛆)提取物多糖对2,4-二硝基氯苯诱导的小鼠特应性皮炎的抗炎和免疫调节作用
Front Pharmacol. 2023 Mar 22;14:1119103. doi: 10.3389/fphar.2023.1119103. eCollection 2023.
6
Potential classification of chemical immunologic response based on gene expression profiles.基于基因表达谱的化学免疫反应的潜在分类。
J Immunotoxicol. 2020 Dec;17(1):122-134. doi: 10.1080/1547691X.2020.1758855.
7
Neonatal-derived IL-17 producing dermal γδ T cells are required to prevent spontaneous atopic dermatitis.新生儿来源的产生白细胞介素-17 的皮肤 γδ T 细胞可预防自发性特应性皮炎。
Elife. 2020 Feb 17;9:e51188. doi: 10.7554/eLife.51188.
8
2D Visualization of the Psoriasis Transcriptome Fails to Support the Existence of Dual-Secreting IL-17A/IL-22 Th17 T Cells.银屑病转录组的 2D 可视化无法支持双分泌 IL-17A/IL-22 Th17 T 细胞的存在。
Front Immunol. 2019 Apr 4;10:589. doi: 10.3389/fimmu.2019.00589. eCollection 2019.
9
Interleukin-22 and Its Correlation with Disease Activity in Plaque Psoriasis.白细胞介素-22 及其与斑块状银屑病疾病活动度的相关性。
Arch Immunol Ther Exp (Warsz). 2019 Apr;67(2):103-108. doi: 10.1007/s00005-018-0527-5. Epub 2018 Oct 5.
10
Consider the chemokines: a review of the interplay between chemokines and T cell subset function.考虑趋化因子:趋化因子与T细胞亚群功能之间相互作用的综述。
Discov Med. 2017 Aug;24(130):31-39.